Skip to content
- 10Multi-institutional retrospective study on CT and pelvic RT for stage IVB cervical cancer_JGOG1088SHas attachmentsThe 2nd EAGOT Annual Meeting 2023 · Koji Nishino (JGOG)Views 2,526
- 9Clinicopathologic ChaRacteristics of cervical cAncer patients having received Simple HysterectomyHas attachmentsThe 2nd EAGOT Annual Meeting 2023 · Kidong Kim (KGOG) and Tae-Wook Kong (KGOG)Views 2,865
- 8Interpretation & application of recent Immunotherapy for GYN Cancer, based on the data in ChinaHas attachmentsThe 2nd EAGOT Annual Meeting 2023 · Hao Wen (CHISGO)Views 2,856
- 7Surgical Challenges in Cervical Cancer Patients with Involved Lymph Nodes –From Clinical Experience–Has attachmentsThe 2nd EAGOT Annual Meeting 2023 · Mikio Mikami (JSGO)Views 2,644
- 6Role of Robotic Surgery for Gynecologic CancerHas attachmentsThe 1st EAGOT Annual Meeting 2023 · Chi-Heum Cho (KGOG)Views 2,696
- 5MACC(MIS Approach to Cervical Cancer) TrialHas attachmentsThe 1st EAGOT Annual Meeting 2023 · Dae-Yeon Kim (KGOG)Views 2,648
- 4[JGOG 1087] JACC trialHas attachmentsThe 1st EAGOT Annual Meeting 2023 · Taichi Mizushima (JGOG)Views 3,250
- 3Discussion about clinical trials or situation of chemotherapy and/or ICIHas attachmentsThe 1st EAGOT Annual Meeting 2023 · Koji Nishino (JGOG)Views 2,781
- 2What is appropriate adjuvant therapy for gastric-type mucinous carcinoma of the uterine cervix?Has attachmentsThe 1st EAGOT Annual Meeting 2023 · Shin Nishio (JGOG)Views 2,677
- 1[The 1st EAGOT Annual Meeting 2023] Program for cervical cancer committeeThe 1st EAGOT Annual Meeting 2023Views 3,578
